SICK A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.0% 0.9% 0.8% 0.8% 0.7%  
Credit score (0-100)  88 89 89 92 95  
Credit rating  A A AA AA AA  
Credit limit (kDKK)  1,757.0 2,825.0 4,131.7 5,329.9 5,281.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  35,043 37,166 43,215 44,246 48,610  
EBITDA  10,660 11,173 15,537 14,280 17,751  
EBIT  9,106 9,399 13,662 13,415 15,985  
Pre-tax profit (PTP)  8,999.1 9,264.7 13,712.1 13,597.0 16,849.3  
Net earnings  7,038.9 7,205.3 10,621.0 10,562.1 13,120.3  
Pre-tax profit without non-rec. items  8,999 9,265 13,712 13,597 16,849  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,453 2,269 1,219 2,064 9,257  
Shareholders equity total  18,371 25,577 36,198 46,760 39,880  
Interest-bearing liabilities  28,490 7,764 28,169 35,115 39,951  
Balance sheet total (assets)  58,737 47,896 75,516 93,474 96,017  

Net Debt  27,775 7,053 27,457 34,407 39,440  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  35,043 37,166 43,215 44,246 48,610  
Gross profit growth  1.2% 6.1% 16.3% 2.4% 9.9%  
Employees  32 33 34 36 37  
Employee growth %  6.7% 3.1% 3.0% 5.9% 2.8%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  58,737 47,896 75,516 93,474 96,017  
Balance sheet change%  24.6% -18.5% 57.7% 23.8% 2.7%  
Added value  9,105.5 9,399.3 13,662.3 13,415.3 15,985.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  2,217 -3,086 -3,054 -106 5,450  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  26.0% 25.3% 31.6% 30.3% 32.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.4% 18.6% 22.3% 16.2% 18.2%  
ROI %  21.2% 23.1% 27.2% 18.5% 20.4%  
ROE %  36.2% 32.8% 34.4% 25.5% 30.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  31.3% 53.4% 47.7% 49.9% 41.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  260.5% 63.1% 176.7% 240.9% 222.2%  
Gearing %  155.1% 30.4% 77.8% 75.1% 100.2%  
Net interest  0 0 0 0 0  
Financing costs %  1.0% 3.5% 0.3% 0.4% 1.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.4 2.4 1.9 2.0 1.7  
Current Ratio  1.4 2.4 1.9 2.0 1.7  
Cash and cash equivalent  714.4 711.7 711.7 708.0 510.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  16,778.8 26,544.5 35,320.0 45,681.0 36,984.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  285 285 402 373 432  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  333 339 457 397 480  
EBIT / employee  285 285 402 373 432  
Net earnings / employee  220 218 312 293 355